Cipla Quarterly Results for Trading Insights

CIPLA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,353 Cr
QSept 2025
Quarterly Results

Cipla Quarterly Results Key Highlights

  • Revenue of ₹7,716 Cr in Sept 2025 (+12.0% vs Mar 2025, +7.9% vs Sept 2024)
  • Net Profit of ₹1,353 Cr in Sept 2025 (+11.4% vs Mar 2025, +3.7% vs Sept 2024)
  • EBITDA of ₹2,022 Cr in Sept 2025 (+19.3% vs Mar 2025)
  • Operating Margin of 24.0% in Sept 2025 (+3.0pp vs Mar 2025)
  • Earnings Per Share of ₹16.73 in Sept 2025 (+10.6% vs Mar 2025)

Cipla Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 7,716 6,887 7,096 7,169 7,152 12.0% 7.9%
Net Profit (₹ Cr) 1,353 1,214 1,292 674 1,305 - -
EBITDA (₹ Cr) 2,022 1,695 1,916 1,074 1,986 - -
EPS (₹) 16.73 15.13 16.07 8.37 16.13 - -
Operating Margin (%) 24.0% 21.0% 24.0% 12.0% 26.0% - -

Cipla Share Price Trend Around Quarterly Results

Visualize Cipla's 1-year price movement across quarterly results — ideal for logging trades in Cipla share price chart using Tickjournal. All values in ₹.

Related Pages for Cipla

Additional stock information and data for CIPLA

CIPLA balance sheet details
CIPLA price movement history
CIPLA earnings valuation
CIPLA dividend track record
Cipla shareholding analysis
Cipla P/B ratio trends
CIPLA price range
CIPLA stock valuation models

Profitability Ratios

Profit Margin 17.5%
EBITDA Margin 26.2%
Operating Margin 24.0%
ROE (Annual) 17.3%

Balance Sheet Highlights

Total Assets ₹37,387 Cr
Total Equity ₹31,289 Cr
Current Assets ₹23,249 Cr
Current Liabilities ₹614 Cr

Cash Flow Analysis

Operating Cash Flow ₹5,005 Cr
Investing Cash Flow ₹-3,682 Cr
Financing Cash Flow ₹-1,293 Cr
Net Cash Flow ₹30 Cr

Current Market Data

Current Price ₹1341.10
Exchange NSE
Last Updated Feb 20, 2026

Revenue Trend (₹ Cr)

Dec 2025 7,169
Jun 2025 7,096
Mar 2025 6,887
Sept 2025 7,716

Net Profit Trend (₹ Cr)

Dec 2025 674
Jun 2025 1,292
Mar 2025 1,214
Sept 2025 1,353

Operating Margin Trend (%)

Dec 2025 12.0%
Jun 2025 24.0%
Mar 2025 21.0%
Sept 2025 24.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Cipla quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹413,741.32 Cr 1724.4 14,875 3,125 +10.8% - 21.0% 132.6
Divis Laboratories
Sept 2025 		₹167,006.28 Cr 6291.0 2,860 689 +7.1% - 24.1% 242.2
Torrent Pharmaceuti…
Sept 2025 		₹138,018.05 Cr 4241.7 3,219 591 +11.3% - 18.4% 241.8
Dr Reddys Laborator…
Sept 2025 		₹106,866.07 Cr 1280.4 9,135 1,337 +1.1% - 14.6% 79.1
Lupin
Sept 2025 		₹100,463.76 Cr 2219.4 6,921 1,485 +23.2% - 21.5% 68.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores